PSK, I have been here equally as long if not longer so I certainly and totally understand your doubts! Within reach and what that means is hard to say, that will all depend on the speed of progress. With NR2F6 this is probably the most in reach ENTB has been. Entest has reconfigured its therapy approach over time.
IMO they should by now know if this works in animals(dogs/cats) given prior testing and the most recent patent application. Nothing is absolute in development so of course you have to use words like believe and should. Though the PR's around NR2F6 with Regen look promising and that NR2F6 expression or inhibition works. New applications continue.
News 
Market Data 
Discover 
